Pityriasis rubra pilaris‐like eruption following administration of the BNT163b2 (Pfizer–BioNTech) mRNA COVID‐19 vaccine
Manrup Hunjan, C Michael Roberts, Saad Kazim Karim, J. S. Hague
Abstract
We describe a case of a pityriasis rubra pilaris (PRP)-like eruption occurring following administration of the Pfizer-Biontech mRNA COVID-19 vaccine, with worsening of the condition following the second dose. To our knowledge, this is the first reported case of a PRP-like eruption as a cutaneous adverse event of the Pfizer-Biontech mRNA COVID-19 vaccine.
Topics & Concepts
Pityriasis rubra pilarisMedicineDermatologyCoronavirus disease 2019 (COVID-19)PathologyDiseaseInfectious disease (medical specialty)PsoriasisDermatological and COVID-19 studiesPsoriasis: Treatment and PathogenesisHerpesvirus Infections and Treatments